CLDX Celldex Therapeutics, Inc.
CLDX Celldex Therapeutics, Inc.
Healthcare · Biotechnology
Desk view
Market read
POC $30.26 · VWAP $31.64 · -7.6% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
CLDX Price Structure
Loading timeframes…
Peers
Every watchlist CLDX belongs to, members best 30-day change first — CLDX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How CLDX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about CLDX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 7 days ago · Oct 16
- CLDX Posts Celldex Therapeutics
- CLDX - Celldex Therapeutics Inc. stock news, filings & ratings | Quantisnow
- CLDX Stock Price, Quote & Chart | ChartMill.com
- Investors - Celldex Therapeutics
- CLDX Q2 2026 Earnings Report on 8/6/2026 - MarketBeat
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
CLDX research tape
42 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.